BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Klion A, Bochner B, Gleich G, Nutman T, Rothenberg M, Simon H, Wechsler M, Weller P, Thehypereosinophilicsyndromesw. Approaches to the treatment of hypereosinophilic syndromes: A workshop summary report. Journal of Allergy and Clinical Immunology 2006;117:1292-302. [DOI: 10.1016/j.jaci.2006.02.042] [Cited by in Crossref: 243] [Cited by in F6Publishing: 169] [Article Influence: 15.2] [Reference Citation Analysis]
Number Citing Articles
1 Celli B. Is the Blood Eosinophil Count a Useful Biomarker in COPD? The devil is in the Details! Archivos de Bronconeumología 2017;53:415-6. [DOI: 10.1016/j.arbres.2017.01.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
2 Wolpin BM, Weller PF, Katz JT, Levy BD, Loscalzo J. Clinical problem-solving. The writing on the wall. N Engl J Med 2009;361:1387-92. [PMID: 19797286 DOI: 10.1056/NEJMcps0707685] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
3 Coumou H, Bel EH. Improving the diagnosis of eosinophilic asthma. Expert Rev Respir Med 2016;10:1093-103. [PMID: 27624868 DOI: 10.1080/17476348.2017.1236688] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
4 Guillevin L. Advances in the Treatments of Systemic Vasculitides. Clinic Rev Allerg Immunol 2008;35:72-8. [DOI: 10.1007/s12016-007-8068-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
5 Fernandez AB, Ahmed S, Duncan B, Firshein S, Kluger J. Cardiac tamponade: a rare complication of idiopathic hypereosinophilic syndrome. Journal of Cardiovascular Medicine 2009;10:188-91. [DOI: 10.2459/jcm.0b013e32831cf005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Zaccaria E, Drago F, Rossi E, Rebora A. T-cell-associated hypereosinophilic syndrome
Case report and an appraisal of the new classification. Journal of the European Academy of Dermatology and Venereology 2008;22:1120-1. [DOI: 10.1111/j.1468-3083.2007.02464.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
7 Menif S, Ben Romdhane N, Hafsia R. [Efficacy of imatinib in FIP1L1-PDGFRA positive hypereosinophilic syndrome]. Rev Med Interne 2008;29:65-7. [PMID: 18036706 DOI: 10.1016/j.revmed.2007.09.036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
8 Lee RU, Stevenson DD. Hydroxyurea in the treatment of Churg-Strauss syndrome. Journal of Allergy and Clinical Immunology 2009;124:1110-1. [DOI: 10.1016/j.jaci.2009.06.037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
9 Sato Y, Fukunaga T, Hayashi T, Asada Y. Hypereosinophilic syndrome associated with occlusive coronary thrombosis and right ventricular thrombus. Pathol Int 2008;58:138-41. [PMID: 18199165 DOI: 10.1111/j.1440-1827.2007.02202.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
10 Wechsler ME, Fulkerson PC, Bochner BS, Gauvreau GM, Gleich GJ, Henkel T, Kolbeck R, Mathur SK, Ortega H, Patel J. Novel targeted therapies for eosinophilic disorders. J Allergy Clin Immunol. 2012;130:563-571. [PMID: 22935585 DOI: 10.1016/j.jaci.2012.07.027] [Cited by in Crossref: 71] [Cited by in F6Publishing: 66] [Article Influence: 7.1] [Reference Citation Analysis]
11 Sekkach Y, Mekouar F, Jira M, Elqatni M, Elomri N, Fatihi J, Badaoui M, Hammi S, Smaali J, El Khattabi A, Amezyane T, Abouzahir A, Ghafir D. [Durable efficacity and remission after treatment with imatinib mesylate for FIP1L1-PDGFRA transcript negative associated eosinophilic cardiomyopathy]. Ann Pharm Fr 2011;69:277-81. [PMID: 21924129 DOI: 10.1016/j.pharma.2011.07.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
12 Williams KW, Ware J, Abiodun A, Holland-Thomas NC, Khoury P, Klion AD. Hypereosinophilia in Children and Adults: A Retrospective Comparison. J Allergy Clin Immunol Pract 2016;4:941-947.e1. [PMID: 27130711 DOI: 10.1016/j.jaip.2016.03.020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
13 Wagelie-Steffen A, Aceves SS. Eosinophilic disorders in children. Curr Allergy Asthma Rep 2006;6:475-82. [PMID: 17026874 DOI: 10.1007/s11882-006-0024-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
14 Knutsen AP, Temprano J, Wooldridge JL, Bhatla D, Slavin RG. Environmental Exposures in the Normal Host. Kendig & Chernick’s Disorders of the Respiratory Tract in Children. Elsevier; 2012. pp. 858-76. [DOI: 10.1016/b978-1-4377-1984-0.00059-0] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
15 Roldán Montaud A, Citores Sánchez MJ, Perales Fraile I, Masip Marzá V, Bellas Menéndez C, Vargas Núñez JA. [Lymphocytic variant of the hypereosinophilic syndrome]. Rev Clin Esp 2009;209:303-8. [PMID: 19635254 DOI: 10.1016/s0014-2565(09)71478-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Hosoki K, Nagao M, Iguchi K, Ihara T, Yamada Y, Higashigawa M, Kephart GM, Kita H, Fujisawa T. An 8-Year-Old Boy with Hypereosinophilic Syndrome. Int Arch Allergy Immunol 2011;155:117-22. [DOI: 10.1159/000327495] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
17 Roufosse FE, Goldman M, Cogan E. Hypereosinophilic syndromes. Orphanet J Rare Dis 2007;2:37. [PMID: 17848188 DOI: 10.1186/1750-1172-2-37] [Cited by in Crossref: 99] [Cited by in F6Publishing: 70] [Article Influence: 6.6] [Reference Citation Analysis]
18 Mehr S, Rego S, Kakakios A, Kilham H, Kemp A. Treatment of a Case of Pediatric Hypereosinophilic Syndrome with Anti-Interleukin-5. The Journal of Pediatrics 2009;155:289-91. [DOI: 10.1016/j.jpeds.2009.01.058] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
19 Dulohery MM, Patel RR, Schneider F, Ryu JH. Lung involvement in hypereosinophilic syndromes. Respir Med. 2011;105:114-121. [PMID: 21036585 DOI: 10.1016/j.rmed.2010.09.011] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
20 Moerman-Herzog AM, Acheampong DA, Brooks AG, Blair SM, Hsu PC, Wong HK. Transcriptome analysis of Sézary syndrome and lymphocytic-variant hypereosinophilic syndrome T cells reveals common and divergent genes. Oncotarget 2019;10:5052-69. [PMID: 31489115 DOI: 10.18632/oncotarget.27120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Seo P. Eosinophilic Granulomatosis with Polyangiitis: Challenges and Opportunities. J Allergy Clin Immunol Pract 2016;4:520-1. [PMID: 27157939 DOI: 10.1016/j.jaip.2016.03.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Komatsu J, Kida R, Kubokawa SI, Ohkawa Y, Sakaeda H, Kuzume D, Yamasaki M, Kawai K, Hamashige N, Doi Y. Eosinophilic myocarditis associated with hypereosinophilic syndromes. Geriatr Gerontol Int 2020;20:727-9. [PMID: 32691926 DOI: 10.1111/ggi.13930] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Straumann A. Idiopathic eosinophilic gastrointestinal diseases in adults. Best Pract Res Clin Gastroenterol. 2008;22:481-496. [PMID: 18492567 DOI: 10.1016/j.bpg.2007.09.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
24 Brambatti M, Matassini MV, Adler ED, Klingel K, Camici PG, Ammirati E. Eosinophilic Myocarditis: Characteristics, Treatment, and Outcomes. J Am Coll Cardiol. 2017;70:2363-2375. [PMID: 29096807 DOI: 10.1016/j.jacc.2017.09.023] [Cited by in Crossref: 78] [Cited by in F6Publishing: 63] [Article Influence: 15.6] [Reference Citation Analysis]
25 Alzayer H, Hasan MA. Hypereosinophilic vasculitis: A case report. Medicine (Baltimore) 2019;98:e15392. [PMID: 31027135 DOI: 10.1097/MD.0000000000015392] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Mormile I, Petraroli A, Loffredo S, Rossi FW, Mormile M, Del Mastro A, Spadaro G, de Paulis A, Bova M. Episodic Angioedema with Hypereosinophilia (Gleich's Syndrome): A Case Report and Extensive Review of the Literature. J Clin Med 2021;10:1442. [PMID: 33916211 DOI: 10.3390/jcm10071442] [Reference Citation Analysis]
27 Peroš-golubičić T, Smojver-ježek S. Hypereosinophilic syndrome: diagnosis and treatment: . Current Opinion in Pulmonary Medicine 2007;13:422-7. [DOI: 10.1097/mcp.0b013e3281eb8eb8] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
28 Fletcher S, Bain B. Diagnosis and treatment of hypereosinophilic syndromes. Curr Opin Hematol. 2007;14:37-42. [PMID: 17133098 DOI: 10.1097/00062752-200701000-00008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
29 Klion AD. Eosinophilic myeloproliferative disorders. Hematology Am Soc Hematol Educ Program 2011;2011:257-63. [PMID: 22160043 DOI: 10.1182/asheducation-2011.1.257] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
30 Pagnoux C, Guillevin L. Churg-Strauss syndrome: evidence for disease subtypes? Curr Opin Rheumatol 2010;22:21-8. [PMID: 19851111 DOI: 10.1097/BOR.0b013e328333390b] [Cited by in Crossref: 66] [Cited by in F6Publishing: 26] [Article Influence: 5.5] [Reference Citation Analysis]
31 Herrero B, de la Fuente JR, Aleo E, Carceller F, Lassaletta Á, Orellana MR, Pérez-Martínez A. Spontaneous resolution of hypereosinophilic syndrome in an infant without treatment. J Pediatr Hematol Oncol 2012;34:450-2. [PMID: 22510769 DOI: 10.1097/MPH.0b013e318249579b] [Reference Citation Analysis]
32 Ogbogu PU, Rosing DR, Horne MK 3rd. Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am 2007;27:457-75. [PMID: 17868859 DOI: 10.1016/j.iac.2007.07.001] [Cited by in Crossref: 171] [Cited by in F6Publishing: 125] [Article Influence: 11.4] [Reference Citation Analysis]
33 Squillace DL, Checkel JL, Tefferi A, Kita H, Gleich GJ. Development and application of novel immunoassays for eosinophil granule major basic proteins to evaluate eosinophilia and myeloproliferative disorders. J Immunol Methods 2021;493:113015. [PMID: 33689807 DOI: 10.1016/j.jim.2021.113015] [Reference Citation Analysis]
34 Cho HJ, Yoo HS, Kim MA, Shin YS, Ye YM, Nahm DH, Kim JH, Choi JH, Park SY, Park HS. Clinical characteristics of angioedema with eosinophilia. Allergy Asthma Immunol Res 2014;6:362-5. [PMID: 24991461 DOI: 10.4168/aair.2014.6.4.362] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
35 Klion AD. How I treat hypereosinophilic syndromes. Blood 2009;114:3736-41. [PMID: 19692700 DOI: 10.1182/blood-2009-07-143552] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
36 Khoury P, Herold J, Alpaugh A, Dinerman E, Holland-Thomas N, Stoddard J, Gurprasad S, Maric I, Simakova O, Schwartz LB, Fong J, Lee CC, Xi L, Wang Z, Raffeld M, Klion AD. Episodic angioedema with eosinophilia (Gleich syndrome) is a multilineage cell cycling disorder. Haematologica 2015;100:300-7. [PMID: 25527564 DOI: 10.3324/haematol.2013.091264] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
37 Sheikh J, Weller PF. Advances in diagnosis and treatment of eosinophilia. Curr Opin Hematol 2009;16:3-8. [PMID: 19057198 DOI: 10.1097/MOH.0b013e32831c841f] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
38 Sriaroon P, Ballow M. Biological Modulators in Eosinophilic Diseases. Clin Rev Allergy Immunol 2016;50:252-72. [PMID: 25129490 DOI: 10.1007/s12016-014-8444-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
39 Helbig G, Moskwa A, Hus M, Piszcz J, Swiderska A, Urbanowicz A, Całbecka M, Gajkowska J, Seferyńska I, Hałasz M, Woszczyk D, Markiewicz M, Krzemień S. Clinical characteristics of patients with chronic eosinophilic leukaemia (CEL) harbouring FIP1L1-PDGFRA fusion transcript--results of Polish multicentre study. Hematol Oncol 2010;28:93-7. [PMID: 19728396 DOI: 10.1002/hon.919] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
40 Cogan E, Roufosse F. Clinical management of the hypereosinophilic syndromes. Expert Rev Hematol 2012;5:275-89; quiz 290. [PMID: 22780208 DOI: 10.1586/ehm.12.14] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
41 Koizumi R, Sasaki N, Nakamura Y, Suzuki N, Sawai T, Yamauchi K. Rapamycin attenuates pulmonary allergic vasculitis in murine model by reducing TGF-β production in the lung. Allergol Int 2014;63:457-66. [PMID: 24851949 DOI: 10.2332/allergolint.13-OA-0679] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
42 Václavík J, Szotkowski T, Hutyra M, Kozák J, Lukl J, Táborský M. Development of Löffler's endocarditis in FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome despite continuous imatinib mesylate therapy and continuous complete remission. Am J Hematol 2010;85:296-9. [PMID: 20169542 DOI: 10.1002/ajh.21635] [Reference Citation Analysis]
43 Kuang FL, Curtin BF, Alao H, Piligian B, Berry A, Holland-Thomas N, Powers A, Quezado M, Lumbard K, Fay MP, Klion AD, Kumar S, Khoury P. Single-Organ and Multisystem Hypereosinophilic Syndrome Patients with Gastrointestinal Manifestations Share Common Characteristics. J Allergy Clin Immunol Pract 2020;8:2718-2726.e2. [PMID: 32344186 DOI: 10.1016/j.jaip.2020.04.025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
44 Ramzan M, Chopra Y, Grover AK, Yadav SP. Isolated bilateral uveitis in child with hypereosinophilic syndrome. J Pediatr Hematol Oncol 2014;36:e465-7. [PMID: 24390454 DOI: 10.1097/MPH.0000000000000100] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
45 Dinary B, Shaheen K, Eisa N, Alraies MC, Alraiyes AH, Ravakhah K. Hypereosinophilic syndrome induced cystitis mimicking bladder tumor. N Am J Med Sci 2013;5:331-3. [PMID: 23814766 DOI: 10.4103/1947-2714.112488] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
46 . Bibliography. Current world literature. Outcome measures. Curr Opin Allergy Clin Immunol 2007;7:288-90. [PMID: 17489050 DOI: 10.1097/ACI.0b013e3281fbd52a] [Reference Citation Analysis]
47 Blanchard C, Mingler MK, Vicario M, Abonia JP, Wu YY, Lu TX, Collins MH, Putnam PE, Wells SI, Rothenberg ME. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol. 2007;120:1292-1300. [PMID: 18073124 DOI: 10.1016/j.jaci.2007.10.024] [Cited by in Crossref: 311] [Cited by in F6Publishing: 272] [Article Influence: 22.2] [Reference Citation Analysis]
48 Bernheim A, McLoud T. A Review of Clinical and Imaging Findings in Eosinophilic Lung Diseases. AJR Am J Roentgenol 2017;208:1002-10. [PMID: 28225641 DOI: 10.2214/AJR.16.17315] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 2.6] [Reference Citation Analysis]
49 Vallero S, Mondino A, Farinasso L, Ansaldi G, Davitto M, Ramenghi U. Successful use of antihistamines in severe hypereosinophilia. Pediatr Rep 2012;4:e26. [PMID: 25396031 DOI: 10.4081/pr.2012.e26] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
50 Séguéla P, Iriart X, Acar P, Montaudon M, Roudaut R, Thambo J. Eosinophilic cardiac disease: Molecular, clinical and imaging aspects. Archives of Cardiovascular Diseases 2015;108:258-68. [DOI: 10.1016/j.acvd.2015.01.006] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 6.9] [Reference Citation Analysis]
51 Valent P, Gleich GJ, Reiter A, Roufosse F, Weller PF, Hellmann A, Metzgeroth G, Leiferman KM, Arock M, Sotlar K, Butterfield JH, Cerny-Reiterer S, Mayerhofer M, Vandenberghe P, Haferlach T, Bochner BS, Gotlib J, Horny HP, Simon HU, Klion AD. Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field. Expert Rev Hematol 2012;5:157-76. [PMID: 22475285 DOI: 10.1586/ehm.11.81] [Cited by in Crossref: 98] [Cited by in F6Publishing: 82] [Article Influence: 9.8] [Reference Citation Analysis]
52 Mulvey JJ, Magro C, Chadburn A. Resolution of a steroid-resistant, hypereosinophilic immune diathesis with mepolizumab and concomitant amelioration of a mixed thrombotic microangiopathy. Blood Cells Mol Dis 2018;69:38-42. [PMID: 28648630 DOI: 10.1016/j.bcmd.2017.04.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
53 Wechsler ME. Pulmonary Eosinophilic Syndromes. Immunology and Allergy Clinics of North America 2007;27:477-92. [DOI: 10.1016/j.iac.2007.07.005] [Cited by in Crossref: 46] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
54 Klion AD. Approach to the Therapy of Hypereosinophilic Syndromes. Immunology and Allergy Clinics of North America 2007;27:551-60. [DOI: 10.1016/j.iac.2007.07.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
55 Gherasim A, Dao A, Bernstein JA. Confounders of severe asthma: diagnoses to consider when asthma symptoms persist despite optimal therapy. World Allergy Organ J 2018;11:29. [PMID: 30459928 DOI: 10.1186/s40413-018-0207-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
56 Busse WW, Ring J, Huss-Marp J, Kahn JE. A review of treatment with mepolizumab, an anti-IL-5 mAb, in hypereosinophilic syndromes and asthma. J Allergy Clin Immunol 2010;125:803-13. [PMID: 20371394 DOI: 10.1016/j.jaci.2009.11.048] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 5.3] [Reference Citation Analysis]
57 Miloslavsky EM, Stone JH, Unizony SH. Challenging Mimickers of Primary Systemic Vasculitis. Rheumatic Disease Clinics of North America 2015;41:141-60. [DOI: 10.1016/j.rdc.2014.09.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
58 Sheikh J, Weller PF. Clinical overview of hypereosinophilic syndromes. Immunol Allergy Clin North Am 2007;27:333-55. [PMID: 17868853 DOI: 10.1016/j.iac.2007.07.007] [Cited by in Crossref: 46] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
59 Kjeldsen E. A novel acquired cryptic three-way translocation t(2;11;5)(p21.3;q13.5;q23.2) with a submicroscopic deletion at 11p14.3 in an adult with hypereosinophilic syndrome. Exp Mol Pathol 2015;99:50-5. [PMID: 25962659 DOI: 10.1016/j.yexmp.2015.05.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
60 Ogbogu PU, Bochner BS, Butterfield JH, Gleich GJ, Huss-Marp J, Kahn JE, Leiferman KM, Nutman TB, Pfab F, Ring J, Rothenberg ME, Roufosse F, Sajous MH, Sheikh J, Simon D, Simon HU, Stein ML, Wardlaw A, Weller PF, Klion AD. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol. 2009;124:1319-25.e3. [PMID: 19910029 DOI: 10.1016/j.jaci.2009.09.022] [Cited by in Crossref: 336] [Cited by in F6Publishing: 257] [Article Influence: 28.0] [Reference Citation Analysis]
61 Wong TW, Doyle AD, Lee JJ, Jelinek DF. Eosinophils regulate peripheral B cell numbers in both mice and humans. J Immunol 2014;192:3548-58. [PMID: 24616476 DOI: 10.4049/jimmunol.1302241] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
62 Kiani R, Naghavi B, Amin A, Sadeghpour A, Zahedmehr A, Firouzi A, Pouraliakbar HR, Ebrahimi Meymand S, Marashizadeh A, Almasi S. Central Nervous System and Cardiac Involvement in the Hypereosinophilic Syndrome: A Case Report. Immunol Invest 2021;50:356-62. [PMID: 32718188 DOI: 10.1080/08820139.2020.1758131] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
63 Cogan E, Roufosse F. [Eosinophilia, Churg-Strauss syndrome and hypereosinophilic syndrome]. Rev Med Interne 2007;28 Suppl 4:S256-8. [PMID: 17961861 DOI: 10.1016/j.revmed.2007.09.001] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
64 Kahn J, Blétry O, Guillevin L. Hypereosinophilic syndromes. Best Practice & Research Clinical Rheumatology 2008;22:863-82. [DOI: 10.1016/j.berh.2008.09.010] [Cited by in Crossref: 41] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
65 Hansell DM, Lynch DA, Mcadams HP, Bankier AA. Idiopathic diffuse lung diseases. Imaging of Diseases of the Chest. Elsevier; 2010. pp. 641-713. [DOI: 10.1016/b978-0-7234-3496-2.00016-6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
66 Vandenbos F, Figueredo M, Dumon-Gubeno MC, Nicolle I, Tarhini A, Medioni LD, Naman H, Mouroux J. [Clonal eosinophilia revealed by recurrent Staphylococcus aureus infection]. Rev Pneumol Clin 2011;67:167-9. [PMID: 21665081 DOI: 10.1016/j.pneumo.2011.02.001] [Reference Citation Analysis]
67 Chao BH, Cline-Parhamovich K, Grizzard JD, Smith TJ. Fatal Loeffler's endocarditis due to hypereosinophilic syndrome. Am J Hematol 2007;82:920-3. [PMID: 17534930 DOI: 10.1002/ajh.20933] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
68 Carpentier C, Schandené L, Dewispelaere L, Heimann P, Cogan E, Roufosse F. CD3−CD4+ Lymphocytic Variant Hypereosinophilic Syndrome: Diagnostic Tools Revisited. The Journal of Allergy and Clinical Immunology: In Practice 2021;9:2426-2439.e7. [DOI: 10.1016/j.jaip.2021.01.030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
69 Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P, Kay AB, Rothenberg ME. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy. 2008;38:709-750. [PMID: 18384431 DOI: 10.1111/j.1365-2222.2008.02958.x] [Cited by in Crossref: 514] [Cited by in F6Publishing: 471] [Article Influence: 36.7] [Reference Citation Analysis]
70 Strati P, Cortes J, Faderl S, Kantarjian H, Verstovsek S. Long-term follow-up of patients with hypereosinophilic syndrome treated with Alemtuzumab, an anti-CD52 antibody. Clin Lymphoma Myeloma Leuk 2013;13:287-91. [PMID: 23123105 DOI: 10.1016/j.clml.2012.09.018] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
71 Holle JU, Moosig F, Gross WL. Diagnostic and therapeutic management of Churg-Strauss syndrome. Expert Rev Clin Immunol 2009;5:813-23. [PMID: 20477699 DOI: 10.1586/eci.09.41] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
72 Leru PM. Eosinophilic disorders: evaluation of current classification and diagnostic criteria, proposal of a practical diagnostic algorithm. Clin Transl Allergy 2019;9:36. [PMID: 31367340 DOI: 10.1186/s13601-019-0277-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
73 Farruggia P, D'angelo P, Acquaviva A, Trizzino A, Tucci F, Cilloni D, Messa F, D'ambrosio A, Aricò M. HYPEREOSINOPHILIC SYNDROME IN CHILDHOOD: Clinical and Molecular Features of Two Cases. Pediatric Hematology and Oncology 2009;26:129-35. [DOI: 10.1080/08880010902773024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
74 Burris D, Rosenberg CE, Schwartz JT, Zhang Y, Eby MD, Abonia JP, Fulkerson PC. Pediatric Hypereosinophilia: Characteristics, Clinical Manifestations, and Diagnoses. J Allergy Clin Immunol Pract 2019;7:2750-2758.e2. [PMID: 31128377 DOI: 10.1016/j.jaip.2019.05.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
75 von Gunten S, Simon HU. Granulocyte death regulation by naturally occurring autoantibodies. Adv Exp Med Biol 2012;750:157-72. [PMID: 22903673 DOI: 10.1007/978-1-4614-3461-0_12] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
76 Banerji A, Weller PF, Sheikh J. Cytokine-associated angioedema syndromes including episodic angioedema with eosinophilia (Gleich's Syndrome). Immunol Allergy Clin North Am 2006;26:769-81. [PMID: 17085290 DOI: 10.1016/j.iac.2006.09.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
77 Jacobs K, Kligerman S. Immune-Mediated Lung Diseases. Seminars in Ultrasound, CT and MRI 2019;40:213-28. [DOI: 10.1053/j.sult.2018.11.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
78 Corren J. Anti-interleukin-5 antibody therapy in asthma and allerges. Current Opinion in Allergy & Clinical Immunology 2011;11:565-70. [DOI: 10.1097/aci.0b013e32834c3d30] [Cited by in Crossref: 39] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
79 Malfuson JV, Fagot T, Konopacki J, Mangouka L, Souleau B, de Revel T. [Hematological disorders and hypereosinophilias]. Rev Med Interne 2009;30:322-30. [PMID: 19201511 DOI: 10.1016/j.revmed.2008.10.019] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
80 Zachée P. Atypical myeloproliferative disorders in adults. Transfusion and Apheresis Science 2011;44:211-21. [DOI: 10.1016/j.transci.2011.01.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
81 Stone KD, Prussin C, Metcalfe DD. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol. 2010;125:S73-S80. [PMID: 20176269 DOI: 10.1016/j.jaci.2009.11.017] [Cited by in Crossref: 647] [Cited by in F6Publishing: 574] [Article Influence: 53.9] [Reference Citation Analysis]
82 Hsieh FH. Hypereosinophilic syndrome. Ann Allergy Asthma Immunol 2014;112:484-8. [PMID: 24726650 DOI: 10.1016/j.anai.2014.03.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
83 Martinelli G, Rondoni M, Ottaviani E, Paolini S, Baccarani M. Hypereosinophilic Syndrome and Molecularly Targeted Therapy. Seminars in Hematology 2007;44:S4-S16. [DOI: 10.1053/j.seminhematol.2007.02.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
84 Li H, Dai Z, Wang B, Huang W. A case report of eosinophilic myocarditis and a review of the relevant literature. BMC Cardiovasc Disord 2015;15:15. [PMID: 25887327 DOI: 10.1186/s12872-015-0003-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
85 Intermesoli T, Delaini F, Acerboni S, Salmoiraghi S, Spinelli O, Guerini V, Vannucchi AM, Mappa S, Rossi G, Rossi V, Di Bona E, Paratore S, Carobbio A, Rambaldi A, Barbui T, Bassan R. A short low-dose imatinib trial allows rapid identification of responsive patients in hypereosinophilic syndromes. British Journal of Haematology 2009;147:681-5. [DOI: 10.1111/j.1365-2141.2009.07893.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
86 Yamada Y, Hoshino K, Shimojima N, Shinoda M, Obara H, Kawachi S, Fuchimoto Y, Tanabe M, Kitagawa Y, Morikawa Y. Idiopathic hypereosinophilic syndrome in a case with ABO-incompatible liver transplantation for biliary atresia complicated by portal vein thrombosis. Pediatr Transplant. 2010;14:e49-e53. [PMID: 20042017 DOI: 10.1111/j.1399-3046.2009.01170.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
87 Yilmaz I, Kaynar L, Tutar N, Pala C, Canoz O, Buyukoglan H, Gulmez I. Response to imatinib in patient with corticosteroid-unresponsive idiopathic hypereosinophilic syndrome. Rev Port Pneumol (2006) 2016;22:59-60. [PMID: 26416165 DOI: 10.1016/j.rppnen.2015.08.003] [Reference Citation Analysis]
88 Radin M, Bertero L, Roccatello D, Sciascia S. Severe Multi-Organ Failure and Hypereosinophilia: When to Call It "Idiopathic"? J Investig Med High Impact Case Rep 2018;6:2324709618758347. [PMID: 29479541 DOI: 10.1177/2324709618758347] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
89 Kleinfeldt T, Nienaber CA, Kische S, Akin I, Turan RG, Körber T, Schneider H, Ince H. Cardiac manifestation of the hypereosinophilic syndrome: new insights. Clin Res Cardiol 2010;99:419-27. [DOI: 10.1007/s00392-010-0144-8] [Cited by in Crossref: 59] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
90 Simon HU, Cools J. Novel approaches to therapy of hypereosinophilic syndromes. Immunol Allergy Clin North Am 2007;27:519-27. [PMID: 17868862 DOI: 10.1016/j.iac.2007.07.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
91 Helbig G, Moskwa A, Hus M, Woźniczka K, Wieczorkiewicz A, Dziaczkowska-suszek J, Soja A, Bartkowska-chrobok A, Kyrcz-krzemień S. Heterogeneity among characteristics of hypereosinophilic syndromes. Journal of Allergy and Clinical Immunology 2010;125:1399-1401.e2. [DOI: 10.1016/j.jaci.2010.02.024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
92 Kuang FL, Klion AD. Biologic Agents for the Treatment of Hypereosinophilic Syndromes. J Allergy Clin Immunol Pract 2017;5:1502-9. [PMID: 29122152 DOI: 10.1016/j.jaip.2017.08.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
93 Preda V, Henderson C, Woods J. Isolated symptomatic cutaneous disease in hypereosinophilic syndrome. Australasian Journal of Dermatology 2010;51:60-5. [DOI: 10.1111/j.1440-0960.2009.00610.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
94 Greenberger PA, Grammer LC. Pulmonary disorders, including vocal cord dysfunction. J Allergy Clin Immunol 2010;125:S248-54. [PMID: 20176261 DOI: 10.1016/j.jaci.2009.09.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
95 Vaduganathan M, Greene SJ, Butler J, Sabbah HN, Shantsila E, Lip GY, Gheorghiade M. The immunological axis in heart failure: importance of the leukocyte differential. Heart Fail Rev 2013;18:835-45. [PMID: 23054221 DOI: 10.1007/s10741-012-9352-9] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
96 Scranton SE, Wild CA, England RW. Episodic angioedema with eosinophilia: successful treatment with imatinib. Ann Allergy Asthma Immunol 2008;100:172-4. [PMID: 18320923 DOI: 10.1016/S1081-1206(10)60430-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
97 Rosenberg HF, Phipps S, Foster PS. Eosinophil trafficking in allergy and asthma. J Allergy Clin Immunol. 2007;119:1303-1310; quiz 1303-1310. [PMID: 17481712 DOI: 10.1016/j.jaci.2007.03.048] [Cited by in Crossref: 264] [Cited by in F6Publishing: 250] [Article Influence: 17.6] [Reference Citation Analysis]
98 Liao W, Long H, Chang CC, Lu Q. The Eosinophil in Health and Disease: from Bench to Bedside and Back. Clin Rev Allergy Immunol 2016;50:125-39. [PMID: 26410377 DOI: 10.1007/s12016-015-8507-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
99 King B, Lee AI, Choi J. Treatment of Hypereosinophilic Syndrome with Cutaneous Involvement with the JAK Inhibitors Tofacitinib and Ruxolitinib. J Invest Dermatol 2017;137:951-4. [PMID: 27887955 DOI: 10.1016/j.jid.2016.10.044] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
100 Taniguchi M, Tsurikisawa N, Higashi N, Saito H, Mita H, Mori A, Sakakibara H, Akiyama K. Treatment for Churg-Strauss syndrome: induction of remission and efficacy of intravenous immunoglobulin therapy. Allergol Int 2007;56:97-103. [PMID: 17460439 DOI: 10.2332/allergolint.R-07-142] [Cited by in Crossref: 38] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
101 Waseem M, Laureta E. An asthmatic adolescent with a rash and eosinophilia. Pediatr Emerg Care 2007;23:727-30. [PMID: 18090108 DOI: 10.1097/PEC.0b013e3181568016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
102 Valent P. Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders. Blood Rev 2009;23:157-65. [PMID: 19246139 DOI: 10.1016/j.blre.2009.01.001] [Cited by in Crossref: 51] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
103 Jiang P, Wang C, Jin B, Lin Y, Chen S. Eosinophilic cystitis in a patient with hypereosinophila syndrome: A case report. Exp Ther Med 2014;8:49-51. [PMID: 24944595 DOI: 10.3892/etm.2014.1706] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
104 Suzuki N, Sasaki N, Utsumi Y, Nagashima H, Nakamura Y, Yamashita M, Yamauchi K, Sawai T. Effects of imatinib mesylate on pulmonary allergic vasculitis in a murine model. Int J Rheum Dis 2013;16:455-62. [PMID: 23992268 DOI: 10.1111/1756-185X.12075] [Cited by in Crossref: 8] [Article Influence: 0.9] [Reference Citation Analysis]
105 Rapanotti MC, Caruso R, Ammatuna E, Zaza S, Trotta L, Divona M, Cicconi L, Funaro D, Federici G, Amadori S, De Rossi G, Lo-coco F. Molecular characterization of paediatric idiopathic hypereosinophilia: Molecular Features of Paediatric Hypereosinophilia. British Journal of Haematology 2010;151:440-6. [DOI: 10.1111/j.1365-2141.2010.08394.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
106 Tabata R, Tabata C, Katashima Y, Yasumizu R. Effect of cyclosporine on lymphocytic variant hypereosinophilic syndrome. International Immunopharmacology 2013;16:488-91. [DOI: 10.1016/j.intimp.2013.04.033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
107 Mejia R, Nutman TB. Evaluation and differential diagnosis of marked, persistent eosinophilia. Semin Hematol 2012;49:149-59. [PMID: 22449625 DOI: 10.1053/j.seminhematol.2012.01.006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
108 von Gunten S, Simon HU. Cell death modulation by intravenous immunoglobulin. J Clin Immunol 2010;30 Suppl 1:S24-30. [PMID: 20405180 DOI: 10.1007/s10875-010-9411-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
109 Kahn JE, Groh M, Lefèvre G. (A Critical Appraisal of) Classification of Hypereosinophilic Disorders. Front Med (Lausanne) 2017;4:216. [PMID: 29259972 DOI: 10.3389/fmed.2017.00216] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
110 Cheung CC, Constantine M, Ahmadi A, Shiau C, Chen LY. Eosinophilic Myocarditis. The American Journal of the Medical Sciences 2017;354:486-92. [DOI: 10.1016/j.amjms.2017.04.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
111 Shomali W, Gotlib J. World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management. Am J Hematol 2022;97:129-48. [PMID: 34533850 DOI: 10.1002/ajh.26352] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
112 Oikawa Y, Sasaki N, Niisato M, Nakamura Y, Yamauchi K. A phosphatidylinositol 3-kinase inhibitor strongly suppressed pulmonary vascular remodeling of allergic vasculitis in a murine model. Exp Lung Res 2016;42:111-20. [PMID: 26986717 DOI: 10.3109/01902148.2016.1157226] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
113 Wang W, Ma J, Sun X, Ba W, Meng X, Zhu Y, Leng L, Li C. A systems biology approach for defining the potential molecular framework of idiopathic hypereosinophilic syndrome with cutaneous involvement. Biochem Biophys Res Commun 2020;524:567-74. [PMID: 32019674 DOI: 10.1016/j.bbrc.2020.01.131] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
114 Nutman TB. Evaluation and differential diagnosis of marked, persistent eosinophilia. Immunol Allergy Clin North Am 2007;27:529-49. [PMID: 17868863 DOI: 10.1016/j.iac.2007.07.008] [Cited by in Crossref: 70] [Cited by in F6Publishing: 51] [Article Influence: 4.7] [Reference Citation Analysis]
115 van Grotel M, de Hoog M, de Krijger R, Beverloo H, van den Heuvel-eibrink M. Hypereosinophilic syndrome in children. Leukemia Research 2012;36:1249-54. [DOI: 10.1016/j.leukres.2012.05.025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
116 Klion AD. How I treat hypereosinophilic syndromes. Blood 2015;126:1069-77. [PMID: 25964669 DOI: 10.1182/blood-2014-11-551614] [Cited by in Crossref: 99] [Cited by in F6Publishing: 77] [Article Influence: 14.1] [Reference Citation Analysis]
117 Ryan D, Inamullah O, El Husseini N, Wang E, Selim MA, Feng W. The Hypereosinophilic Syndrome - An Unusual Cause of Myocarditis and Cardioembolic Strokes. The American Journal of the Medical Sciences 2022. [DOI: 10.1016/j.amjms.2022.05.019] [Reference Citation Analysis]
118 Marques de Macedo P, de Oliveira LC, Freitas DF, da Rocha JA, Freitas AD, Nucci M, Zancopé-Oliveira RM, Almeida-Paes R, do Valle AC. Acute Paracoccidioidomycosis Due to Paracoccidioides brasiliensis S1 Mimicking Hypereosinophilic Syndrome with Massive Splenomegaly: Diagnostic Challenge. PLoS Negl Trop Dis 2016;10:e0004487. [PMID: 27054891 DOI: 10.1371/journal.pntd.0004487] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
119 Abonia JP, Putnam PE. Mepolizumab in eosinophilic disorders. Expert Rev Clin Immunol 2011;7:411-7. [PMID: 21790283 DOI: 10.1586/eci.11.27] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
120 Ladinsky HT, Elizalde A, Schickler R, Dees PB, Crenshaw ML, Sleasman JW. Hypereosinophilic syndrome and hemimelia in a patient with chromosome 6p22.3 deletion. Pediatr Allergy Immunol 2014;25:500-3. [PMID: 24628666 DOI: 10.1111/pai.12213] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
121 Just J, Bourgoin M, Amat F, Cottel N, Lambert N, Wanin S. Childhood-onset severe hypereosinophilic asthma: efficacy of benralizumab. ERJ Open Res 2020;6:00339-2020. [PMID: 33447610 DOI: 10.1183/23120541.00339-2020] [Reference Citation Analysis]
122 Shomali W, Gotlib J. World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management. Am J Hematol 2019;94:1149-67. [PMID: 31423623 DOI: 10.1002/ajh.25617] [Cited by in Crossref: 78] [Cited by in F6Publishing: 60] [Article Influence: 26.0] [Reference Citation Analysis]
123 Dasanu CA, Cohen S, Bauer F. A curious case of a 'burned-out' hypereosinophilic syndrome. Leuk Res 2011;35:e141-2. [PMID: 21429579 DOI: 10.1016/j.leukres.2011.03.004] [Reference Citation Analysis]
124 Helbig G, Wiśniewska-piąty K, Francuz T, Dziaczkowska-suszek J, Kyrcz-krzemień S. Diversity of clinical manifestations and response to corticosteroids for idiopathic hypereosinophilic syndrome: retrospective study in 33 patients. Leukemia & Lymphoma 2012;54:807-11. [DOI: 10.3109/10428194.2012.731602] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
125 Stein ML, Villanueva JM, Buckmeier BK, Yamada Y, Filipovich AH, Assa'ad AH, Rothenberg ME. Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels. J Allergy Clin Immunol 2008;121:1473-83, 1483.e1-4. [PMID: 18410960 DOI: 10.1016/j.jaci.2008.02.033] [Cited by in Crossref: 95] [Cited by in F6Publishing: 92] [Article Influence: 6.8] [Reference Citation Analysis]
126 Crane MM, Chang CM, Kobayashi MG, Weller PF. Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence. J Allergy Clin Immunol 2010;126:179-81. [PMID: 20639012 DOI: 10.1016/j.jaci.2010.03.035] [Cited by in Crossref: 68] [Cited by in F6Publishing: 53] [Article Influence: 5.7] [Reference Citation Analysis]
127 Frankel SK, Groshong SD, Lynch DA. Invited Commentary. RadioGraphics 2007;27:637-9. [DOI: 10.1148/radiographics.27.3.0270637] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
128 Mattis DM, Wang SA, Lu CM. Contemporary Classification and Diagnostic Evaluation of Hypereosinophilia. Am J Clin Pathol 2020;154:305-18. [PMID: 32525541 DOI: 10.1093/ajcp/aqaa056] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
129 Wagner LA, Speckart S, Cutter B, Gleich GJ. Treatment of FIP1L1/PDGFRA-negative hypereosinophilic syndrome with alemtuzumab, an anti-CD52 antibody. J Allergy Clin Immunol 2009;123:1407-8. [PMID: 19342084 DOI: 10.1016/j.jaci.2009.01.069] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
130 Getsuwan S, Tanpowpong P, Hongeng S, Anurathapan U, Pakakasama S, Treepongkaruna S. Ruxolitinib Treatment in an Adolescent With Chronic Graft-Versus-Host Disease Mimicking Eosinophilic Gastrointestinal Disorders: A Case Report. Transplant Proc 2022:S0041-1345(22)00386-4. [PMID: 35810019 DOI: 10.1016/j.transproceed.2022.05.003] [Reference Citation Analysis]
131 He YQ, Zhao YN, Zhu JM, Zhang MC, Liu L, Zeng H, Yang P. Imaging diagnosis for left ventricular thrombosis in idiopathic hypereosinophilic syndrome: two case reports. Medicine (Baltimore) 2014;93:e82. [PMID: 25275526 DOI: 10.1097/MD.0000000000000082] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
132 Wang YB, Han YJ, Uchida K, Zhao BC, Chen KB, Ma WY, Xie FJ, Liu TL, Zhang LX. Pneumothorax as the initial manifestation of idiopathic hypereosinophilic syndrome. Ann Thorac Surg 2014;98:1838-41. [PMID: 25441802 DOI: 10.1016/j.athoracsur.2013.12.078] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
133 Yılmaz İ, Kaynar L, Tutar N, Pala Ç, Canöz Ö, Yıldırım A, Büyükoğlan H, Gülmez İ. Response of Complex Undefined Hypereosinophilic Syndrome to Treatment with Imatinib. Turk Thorac J 2016;17:118-21. [PMID: 29404138 DOI: 10.5578/ttj.30508] [Reference Citation Analysis]
134 Janson C, Bjermer L, Lehtimäki L, Kankaanranta H, Karjalainen J, Altraja A, Yasinska V, Aarli B, Rådinger M, Hellgren J, Lofdahl M, Howarth PH, Porsbjerg C. Eosinophilic airway diseases: basic science, clinical manifestations and future challenges. Eur Clin Respir J 2022;9:2040707. [PMID: 35251534 DOI: 10.1080/20018525.2022.2040707] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
135 Nanagas VC, Kovalszki A. Gastrointestinal manifestations of hypereosinophilic syndromes and mast cell disorders: a comprehensive review. Clin Rev Allergy Immunol. 2018;. [PMID: 30003499 DOI: 10.1007/s12016-018-8695-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
136 Martinaud C, Souraud JB, Cournac JM, Pons S, Ménard G, de Jaureguiberry JP, Brisou P. [Synchronous detection of T-cell clonality and FIP1L1-PDGFRA fusion gene in a hypereosinophilic syndrome]. Rev Med Interne 2011;32:e66-8. [PMID: 20633965 DOI: 10.1016/j.revmed.2010.06.003] [Reference Citation Analysis]
137 Simon D, Simon HU. Eosinophilic disorders. J Allergy Clin Immunol 2007;119:1291-300; quiz 1301-2. [PMID: 17399779 DOI: 10.1016/j.jaci.2007.02.010] [Cited by in Crossref: 110] [Cited by in F6Publishing: 89] [Article Influence: 7.3] [Reference Citation Analysis]
138 Salih M, Ibrahim R, Tirunagiri D, Al-Ani H, Ananthasubramaniam K. Loeffler's Endocarditis and Hypereosinophilic Syndrome. Cardiol Rev 2021;29:150-5. [PMID: 32520731 DOI: 10.1097/CRD.0000000000000324] [Reference Citation Analysis]
139 Butt NM, Lambert J, Ali S, Beer PA, Cross NC, Duncombe A, Ewing J, Harrison CN, Knapper S, McLornan D, Mead AJ, Radia D, Bain BJ; British Committee for Standards in Haematology. Guideline for the investigation and management of eosinophilia. Br J Haematol. 2017;176:553-572. [PMID: 28112388 DOI: 10.1111/bjh.14488] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 9.4] [Reference Citation Analysis]
140 Beedupalli J, Modi K. Early-Stage Loeffler's Endocarditis with Isolated Right Ventricular Involvement: Management, Long-Term Follow-Up, and Review of Literature. Echocardiography 2016;33:1422-7. [PMID: 27172873 DOI: 10.1111/echo.13264] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
141 Park TY, Choi CH, Yang SY, Oh IS, Song ID, Lee HW, Kim HJ, Do JH, Chang SK, Cho AR, Cha YJ. A case of hypereosinophilic syndrome presenting with intractable gastric ulcers. World J Gastroenterol 2009; 15(48): 6129-6133 [PMID: 20027690 DOI: 10.3748/wjg.15.6129] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
142 Romero Fernández E, Pardo JR, Doyle A, Albendea MC, de la Rúa AR. Hemophagocytic syndrome associated NK/T nasal type lymphoma presenting as hypereosinophilic syndrome: a case report and literature review. Leuk Res 2011;35:e97-9. [PMID: 21501869 DOI: 10.1016/j.leukres.2010.12.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
143 Simon HU, Rothenberg ME, Bochner BS, Weller PF, Wardlaw AJ, Wechsler ME, Rosenwasser LJ, Roufosse F, Gleich GJ, Klion AD. Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol 2010;126:45-9. [PMID: 20639008 DOI: 10.1016/j.jaci.2010.03.042] [Cited by in Crossref: 198] [Cited by in F6Publishing: 148] [Article Influence: 16.5] [Reference Citation Analysis]
144 Curtis C, Ogbogu PU. Evaluation and Differential Diagnosis of Persistent Marked Eosinophilia. Immunol Allergy Clin North Am 2015;35:387-402. [PMID: 26209891 DOI: 10.1016/j.iac.2015.04.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
145 Pardanani A, Tefferi A. Primary eosinophilic disorders: a concise review. Curr Hematol Malig Rep 2008;3:37-43. [PMID: 20425445 DOI: 10.1007/s11899-008-0007-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
146 Praharaj DL, Mallick B, Nath P, Panigrahi SC, Anand AC, Sharma R. Hyper-eosinophilic syndrome: An uncommon cause of chronic abdominal pain in an elderly male. Trop Doct 2021;:49475520987765. [PMID: 33472567 DOI: 10.1177/0049475520987765] [Reference Citation Analysis]
147 Hogan SP. Recent advances in eosinophil biology. Int Arch Allergy Immunol 2007;143 Suppl 1:3-14. [PMID: 17541270 DOI: 10.1159/000101398] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
148 Kalra A, Palaniswamy C, Kalra A, Wig N, Sood R. Management of F/P+/- hypereosinophilic syndromes: case report and treatment review. Am J Ther 2012;19:e146-51. [PMID: 20724910 DOI: 10.1097/MJT.0b013e3181ee7370] [Reference Citation Analysis]
149 Furuta GT. Emerging questions regarding eosinophilʼs role in the esophago-gastrointestinal tract: . Current Opinion in Gastroenterology 2006;22:658-63. [DOI: 10.1097/01.mog.0000245530.35518.3e] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
150 Roufosse F. Hypereosinophilic syndrome variants: diagnostic and therapeutic considerations. Haematologica 2009;94:1188-93. [PMID: 19734412 DOI: 10.3324/haematol.2009.010421] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
151 Srinivasan A, Lavanya R, Sankar J. Steroid-unresponsive hypereosinophilic syndrome. Ann Trop Paediatr 2011;31:273-7. [PMID: 21781426 DOI: 10.1179/1465328111Y.0000000027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
152 Hellmich B, Holl-ulrich K, Merz H, Gross W. Hypereosinophiles Syndrom und Churg-Strauss-Syndrom: Ist die Differenzierung der Syndrome klinisch relevant? Internist 2008;49:286-96. [DOI: 10.1007/s00108-007-2009-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
153 Gleich GJ, Leiferman KM. The hypereosinophilic syndromes: current concepts and treatments. Br J Haematol 2009;145:271-85. [PMID: 19243381 DOI: 10.1111/j.1365-2141.2009.07599.x] [Cited by in Crossref: 83] [Cited by in F6Publishing: 51] [Article Influence: 6.4] [Reference Citation Analysis]
154 Akuthota P, Weller PF. Eosinophilic pneumonias. Clin Microbiol Rev 2012;25:649-60. [PMID: 23034324 DOI: 10.1128/CMR.00025-12] [Cited by in Crossref: 58] [Cited by in F6Publishing: 30] [Article Influence: 6.4] [Reference Citation Analysis]
155 Sénéchal M, Bernard PL, Cloutier S, Leblanc MH, Larose É, Cinq-Mars A, Dubois M. Management of Loeffler's Endocarditis With Bivalvular Involvement and a FIP1L1/PDGFRA-Negative Mutation. Can J Cardiol 2016;32:1577.e9-1577.e11. [PMID: 26975226 DOI: 10.1016/j.cjca.2015.12.034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
156 Li H, Groshong SD, Lynch D, Brown KK, Frankel SK. Eosinophilic Lung Disease. Clinical Pulmonary Medicine 2010;17:66-74. [DOI: 10.1097/cpm.0b013e3181d2a1d6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
157 Ishida T, Murayama T, Kobayashi S. Pneumonia and seizures due to hypereosinophilic syndrome—organ damage and eosinophilia without synchronisation: A case report. World J Clin Cases 2022; 10(18): 6325-6332 [DOI: 10.12998/wjcc.v10.i18.6325] [Reference Citation Analysis]
158 Fernández Pérez ER, Olson AL, Frankel SK. Eosinophilic lung diseases. Med Clin North Am 2011;95:1163-87. [PMID: 22032433 DOI: 10.1016/j.mcna.2011.08.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
159 Wechsler ME, Wong DA, Miller MK, Lawrence-Miyasaki L. Churg-strauss syndrome in patients treated with omalizumab. Chest 2009;136:507-18. [PMID: 19411292 DOI: 10.1378/chest.08-2990] [Cited by in Crossref: 89] [Cited by in F6Publishing: 58] [Article Influence: 6.8] [Reference Citation Analysis]
160 Khwaja GA, Duggal A, Kulkarni A, Choudhary N, Gupta M, Chowdhury D, Bohra V, Zutshi D. Hypereosinophilia-an unusual cause of multiple embolic strokes and multi-organ dysfunction. J Clin Diagn Res 2013;7:2316-8. [PMID: 24298517 DOI: 10.7860/JCDR/2013/6004.3512] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
161 Shehwaro N, Langlois AL, Gueutin V, Izzedine H. Renal involvement in idiopathic hypereosinophic syndrome. Clin Kidney J 2013;6:272-6. [PMID: 26064485 DOI: 10.1093/ckj/sft046] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
162 Ibrahim T, Blanke F, Huss-marp J, Will A, von Bubnoff N, Martinoff S, Schömig A. Gadolinium-enhanced cardiovascular magnetic resonance for the detection and characterization of Loeffler endocarditis in patients with hypereosinophilic syndrome. International Journal of Cardiology 2011;153:105-8. [DOI: 10.1016/j.ijcard.2011.09.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
163 Curtis C, Ogbogu P. Hypereosinophilic Syndrome. Clinic Rev Allerg Immunol 2016;50:240-51. [DOI: 10.1007/s12016-015-8506-7] [Cited by in Crossref: 54] [Cited by in F6Publishing: 39] [Article Influence: 7.7] [Reference Citation Analysis]
164 Ackerman SJ, Bochner BS. Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders. Immunol Allergy Clin North Am. 2007;27:357-375. [PMID: 17868854 DOI: 10.1016/j.iac.2007.07.004] [Cited by in Crossref: 67] [Cited by in F6Publishing: 59] [Article Influence: 4.5] [Reference Citation Analysis]
165 Roufosse F, Cogan E, Goldman M. Lymphocytic Variant Hypereosinophilic Syndromes. Immunology and Allergy Clinics of North America 2007;27:389-413. [DOI: 10.1016/j.iac.2007.07.002] [Cited by in Crossref: 104] [Cited by in F6Publishing: 85] [Article Influence: 6.9] [Reference Citation Analysis]
166 Xue J, Jiang J, Liu Y. The Neutrophil/Lymphocyte Ratio is an Independent Predictor of All-Cause Mortality in Patients with Idiopathic Hypereosinophilic Syndrome. JIR 2022;Volume 15:1899-906. [DOI: 10.2147/jir.s357758] [Reference Citation Analysis]
167 Dato I. How to recognize endomyocardial fibrosis?: . Journal of Cardiovascular Medicine 2015;16:547-51. [DOI: 10.2459/jcm.0000000000000165] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
168 Isvy-Joubert A, Hickman G, Flageul B, Battistella M, Bagot M, Galicier L, Petit A. [Myeloproliferative hypereosinophilic syndrome revealed by bipolar mucosal ulcerations]. Ann Dermatol Venereol 2012;139:636-40. [PMID: 23122377 DOI: 10.1016/j.annder.2012.05.008] [Reference Citation Analysis]
169 Smith DA, Minthorn EA, Beerahee M. Pharmacokinetics and pharmacodynamics of mepolizumab, an anti-interleukin-5 monoclonal antibody. Clin Pharmacokinet 2011;50:215-27. [PMID: 21348536 DOI: 10.2165/11584340-000000000-00000] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 5.3] [Reference Citation Analysis]
170 Kandikattu HK, Upparahalli Venkateshaiah S, Mishra A. Synergy of Interleukin (IL)-5 and IL-18 in eosinophil mediated pathogenesis of allergic diseases. Cytokine Growth Factor Rev 2019;47:83-98. [PMID: 31126874 DOI: 10.1016/j.cytogfr.2019.05.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
171 Butterfield JH. Treatment of hypereosinophilic syndromes with prednisone, hydroxyurea, and interferon. Immunol Allergy Clin North Am 2007;27:493-518. [PMID: 17868861 DOI: 10.1016/j.iac.2007.06.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
172 Valent P, Degenfeld-Schonburg L, Sadovnik I, Horny HP, Arock M, Simon HU, Reiter A, Bochner BS. Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity. Semin Immunopathol 2021;43:423-38. [PMID: 34052871 DOI: 10.1007/s00281-021-00863-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
173 Lee J, Dierkhising R, Wu TT, Alexander J, Weiler C. Eosinophilic gastrointestinal disorders (EGID) with peripheral eosinophilia: a retrospective review at Mayo Clinic. Dig Dis Sci. 2011;56:3254-3261. [PMID: 21655949 DOI: 10.1007/s10620-011-1754-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
174 Minupuri A, Ramireddy K, Patel R, Hossain S, Salas Noain J. Hyper-Eosinophilic Syndrome Masquerading as Myocardial Infarction, Stroke and Cancer. Cureus 2020;12:e9630. [PMID: 32923231 DOI: 10.7759/cureus.9630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
175 Noel P. Eosinophilic myeloid disorders. Semin Hematol 2012;49:120-7. [PMID: 22449622 DOI: 10.1053/j.seminhematol.2012.01.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
176 Groh M, Pagnoux C, Baldini C, Bel E, Bottero P, Cottin V, Dalhoff K, Dunogué B, Gross W, Holle J, Humbert M, Jayne D, Jennette JC, Lazor R, Mahr A, Merkel PA, Mouthon L, Sinico RA, Specks U, Vaglio A, Wechsler ME, Cordier JF, Guillevin L. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management. Eur J Intern Med 2015;26:545-53. [PMID: 25971154 DOI: 10.1016/j.ejim.2015.04.022] [Cited by in Crossref: 217] [Cited by in F6Publishing: 171] [Article Influence: 31.0] [Reference Citation Analysis]
177 Kay D, Ataya A, Liu X, Auerbach J, Urbine D. Dysphonia and dyspnea in idiopathic hypereosinophilic syndrome treated with Mepolizumab. Respir Med Case Rep 2018;25:30-2. [PMID: 29998055 DOI: 10.1016/j.rmcr.2018.05.013] [Reference Citation Analysis]
178 Putra J, Goldsmith JD. Daily Dilemmas in Pediatric Gastrointestinal Pathology. Surg Pathol Clin 2020;13:399-411. [PMID: 32773191 DOI: 10.1016/j.path.2020.05.002] [Reference Citation Analysis]
179 Jeon YW, Hong SJ, Kim HJ, Han JP, Kim HK, Ko BM, Park SK, Lee MS. A hypereosinophilic syndrome presenting as eosinophilic colitis. Clin Endosc 2012;45:444-7. [PMID: 23251898 DOI: 10.5946/ce.2012.45.4.444] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
180 Kahn J, Grandpeix-guyodo C, Ackermann F, Charles P, Legrand F, Blétry O. Syndromes hyperéosinophiliques : actualités physiopathologiques et thérapeutiques. La Revue de Médecine Interne 2010;31:268-76. [DOI: 10.1016/j.revmed.2009.05.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
181 Landolina N, Gangwar RS, Levi-Schaffer F. Mast cells' integrated actions with eosinophils and fibroblasts in allergic inflammation: implications for therapy. Adv Immunol 2015;125:41-85. [PMID: 25591464 DOI: 10.1016/bs.ai.2014.09.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
182 Leiferman KM, Gleich GJ, Peters MS. Dermatologic Manifestations of the Hypereosinophilic Syndromes. Immunology and Allergy Clinics of North America 2007;27:415-41. [DOI: 10.1016/j.iac.2007.07.009] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
183 Plötz SG, Hüttig B, Aigner B, Merkel C, Brockow K, Akdis C, Darsow U, Ring J. Clinical overview of cutaneous features in hypereosinophilic syndrome. Curr Allergy Asthma Rep 2012;12:85-98. [PMID: 22359067 DOI: 10.1007/s11882-012-0241-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]